These companies are continuously innovating to develop new GLP-1 receptor agonists with improved efficacy, safety profiles, and convenient administration routes, including oral formulations
They're actually called "orphan receptors" because for years scientists couldn't figure out what natural molecule was supposed to switch them on
However, preliminary data suggests: Tirzepatide: Approximately 33-39% of weight lost was lean mass in SURMOUNT trials Retatrutide: Early data suggests potentially better lean mass preservation, possibly due to glucagon's effects on protein metabolism Regardless of which medication you use, resistance training and adequate protein intake (1.0-1.2g per kg body weight daily) are recommended to minimize muscle loss during treatment
These comparisons underscore a clear mechanism- the more cohesive and opaque the encapsulating matrix, the greater the shielding effect- and they reconcile findings across different formulations
PlexusDx providers can assess your personal risk using the Precision Peptide Genetic Test, which examines genetic variants in GIPR pathways that may predispose you to heightened sensitivity during early treatment phases